Neurodegenerative pathways as targets for acquired epilepsy therapy development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neurodegenerative pathways as targets for acquired epilepsy therapy development

Published:2020-03-12 Issue:2 Volume:5 Page:138-154
ISSN:2470-9239
Container-title:Epilepsia Open
language:en
Short-container-title:Epilepsia Open

Author:

Casillas‐Espinosa Pablo M.¹²^ORCID,Ali Idrish¹²,O'Brien Terence J.¹²³⁴

Affiliation:

1. Departments of Neuroscience and Medicine Central Clinical School Monash University Melbourne Vic. Australia

2. Department of Medicine The Royal Melbourne Hospital The University of Melbourne Melbourne Vic. Australia

3. Department of Neurology The Alfred Hospital Melbourne Vic. Australia

4. Department of Neurology The Royal Melbourne Hospital Parkville Vic. Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12386

Reference299 articles.

1. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009

2. The Global Burden of Epilepsy

3. The global burden and stigma of epilepsy

4. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy

5. Refractory epilepsy: a progressive, intractable but preventable condition?

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study;Journal of Neurotrauma;2024-01-01

2. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine;Journal of Ethnopharmacology;2023-12

3. Neurotrophins and neural stem cells in posttraumatic brain injury repair;Animal Models and Experimental Medicine;2023-11-29

4. Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol;BMJ Open;2023-10

5. Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets;Annals of Neurosciences;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3